SLC6A3 and Parkinson disease: FP-CIT-SPECT was performed in all 18 patients with RBD and in 11 patients with PD and revealed diminished striatal dopamine transporter binding in 10/18 patients with RBD and in all patients with PD (Fig. 3a).